Clinical Trial Update: Regression Discontinuity Design to Evaluate of Drotrecogin Alpha Effectiveness

View source ↗

Summary

A completed study using regression discontinuity design to evaluate the effectiveness of drotrecogin alfa activated in sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Xigris (drotrecogin alfa activated) (drotrecogin alfa activated)

Snippet

Sponsor: Boston Medical Center | Conditions: Sepsis | Status: COMPLETED